Table 2 . Two-dose CoronaVac effectiveness against symptomatic PCR-confirmed COVID-19 infection for entire cohort and for entire cohort excluding participants who had a PCR-confirmed SARS-CoV-2 infection prior to enrolment, during the total study period, and for Delta-predominant period only, Azerbaijan, 2021.